• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉管腔复杂性作为血管痉挛性心绞痛患者难治性症状的新标志物。

Coronary artery lumen complexity as a new marker for refractory symptoms in patients with vasospastic angina.

机构信息

Department of Cardiovascular Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-8510, Japan.

Faculty of Biology-Oriented Science and Technology, Kindai University, 930 Nishimitani, Kinokawa, Wakayama, 649-6493, Japan.

出版信息

Sci Rep. 2021 Jan 8;11(1):13. doi: 10.1038/s41598-020-79669-1.

DOI:10.1038/s41598-020-79669-1
PMID:33420164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7794492/
Abstract

Refractory angina is an independent predictor of adverse events in patients with vasospastic angina (VSA). The aim of this study was to investigate the relationship between coronary lumen complexity and refractory symptoms in patients with VSA. Seventeen patients with VSA underwent optical coherence tomography. The patients were divided into the refractory VSA group (n = 9) and the stable VSA group (n = 8). A shoreline development index was used to assess the coronary artery lumen complexity. Shear stress was estimated using a computational fluid dynamics model. No difference was observed in the baseline characteristics between the two groups. The refractory VSA group showed the higher shoreline development index (refractory VSA 1.042 [1.017-1.188] vs stable VSA 1.003 [1.006-1.025], p = 0.036), and higher maximum medial thickness (refractory VSA 184 ± 17 μm vs stable VSA 148 ± 31 μm, p = 0.017), and higher maximum shear stress (refractory VSA 14.5 [12.1-18.8] Pa vs stable VSA 5.6 [3.0-10.5] Pa, p = 0.003). The shoreline development index positively correlates with shear stress (R = 0.46, P = 0.004). Increased medial thickness of the coronary arteries provokes lumen complexity and high shear stress, which might cause refractory symptoms in patients with VSA. The shoreline index could serve as a marker for irritability of the medial layer of coronary arteries and symptoms.

摘要

难治性心绞痛是血管痉挛性心绞痛(VSA)患者不良事件的独立预测因子。本研究旨在探讨 VSA 患者冠状动脉管腔复杂性与难治性症状之间的关系。17 例 VSA 患者接受光学相干断层扫描。患者分为难治性 VSA 组(n=9)和稳定型 VSA 组(n=8)。采用海岸线发展指数评估冠状动脉管腔复杂性。使用计算流体动力学模型估计切应力。两组患者的基线特征无差异。难治性 VSA 组的海岸线发展指数较高(难治性 VSA 1.042[1.017-1.188] vs 稳定型 VSA 1.003[1.006-1.025],p=0.036),最大中膜厚度较高(难治性 VSA 184±17μm vs 稳定型 VSA 148±31μm,p=0.017),最大切应力较高(难治性 VSA 14.5[12.1-18.8]Pa vs 稳定型 VSA 5.6[3.0-10.5]Pa,p=0.003)。海岸线发展指数与切应力呈正相关(R=0.46,P=0.004)。冠状动脉中膜厚度增加会引起管腔复杂性和高切应力,这可能导致 VSA 患者出现难治性症状。海岸线指数可作为冠状动脉中层易激性和症状的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/fd15311d9d97/41598_2020_79669_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/a95023095ee7/41598_2020_79669_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/2c1cd891d7f4/41598_2020_79669_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/fce9c7d562e5/41598_2020_79669_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/fd15311d9d97/41598_2020_79669_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/a95023095ee7/41598_2020_79669_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/2c1cd891d7f4/41598_2020_79669_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/fce9c7d562e5/41598_2020_79669_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f6/7794492/fd15311d9d97/41598_2020_79669_Fig4_HTML.jpg

相似文献

1
Coronary artery lumen complexity as a new marker for refractory symptoms in patients with vasospastic angina.冠状动脉管腔复杂性作为血管痉挛性心绞痛患者难治性症状的新标志物。
Sci Rep. 2021 Jan 8;11(1):13. doi: 10.1038/s41598-020-79669-1.
2
Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina.变异性心绞痛患者冠脉循环中不对称二甲基精氨酸(ADMA)浓度的意义
Circ J. 2003 Apr;67(4):305-11. doi: 10.1253/circj.67.305.
3
Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina.冠状动脉血管外膜和血管周围脂肪组织炎症与血管痉挛性心绞痛。
J Am Coll Cardiol. 2018 Jan 30;71(4):414-425. doi: 10.1016/j.jacc.2017.11.046.
4
Decreased resting coronary flow and impaired endothelial function in patients with vasospastic angina.变异性心绞痛患者静息冠脉血流减少及内皮功能受损。
Coron Artery Dis. 2019 Jun;30(4):291-296. doi: 10.1097/MCA.0000000000000721.
5
Young Vasospastic Angina Patients Less Than 20 Years Old.年轻(年龄小于 20 岁)血管痉挛性心绞痛患者。
Circ J. 2019 Aug 23;83(9):1925-1928. doi: 10.1253/circj.CJ-19-0433. Epub 2019 Aug 2.
6
OCT-Defined Morphological Characteristics of Coronary Artery Spasm Sites in Vasospastic Angina.OCT 定义的血管痉挛性心绞痛中冠状动脉痉挛部位的形态学特征。
JACC Cardiovasc Imaging. 2015 Sep;8(9):1059-1067. doi: 10.1016/j.jcmg.2015.03.010. Epub 2015 Aug 19.
7
Single-wire pressure and flow velocity measurement for quantifying microvascular dysfunction in patients with coronary vasospastic angina.用于定量检测伴有冠状血管痉挛性心绞痛患者微血管功能障碍的单丝压力和血流速度测量。
Am J Physiol Heart Circ Physiol. 2015 Mar 1;308(5):H478-84. doi: 10.1152/ajpheart.00593.2014. Epub 2014 Dec 19.
8
Thrombus and Plaque Erosion Characterized by Optical Coherence Tomography in Patients With Vasospastic Angina.血管痉挛性心绞痛患者中光学相干断层扫描所显示的血栓与斑块侵蚀
Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):459-466. doi: 10.1016/j.rec.2016.11.003. Epub 2016 Dec 7.
9
Impact of cystatin-C level on the prevalence and angiographic characteristics of vasospastic angina in Korean patients.胱抑素-C水平对韩国患者血管痉挛性心绞痛患病率及血管造影特征的影响。
Int Heart J. 2015;56(1):49-55. doi: 10.1536/ihj.14-213. Epub 2014 Dec 24.
10
Impact of multi-vessel vasospastic angina on cardiovascular outcome.多支血管痉挛性心绞痛对心血管结局的影响。
Atherosclerosis. 2019 Feb;281:107-113. doi: 10.1016/j.atherosclerosis.2018.12.018. Epub 2018 Dec 23.

引用本文的文献

1
Machine learning approaches to predicting medication nonadherence: a scoping review.预测药物治疗不依从性的机器学习方法:一项范围综述。
Int J Med Inform. 2025 Aug 14;204:106082. doi: 10.1016/j.ijmedinf.2025.106082.
2
Coronary Artery Spasm: From Physiopathology to Diagnosis.冠状动脉痉挛:从病理生理学到诊断
Life (Basel). 2025 Apr 3;15(4):597. doi: 10.3390/life15040597.
3
Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review.芍药总苷在皮肤病中的治疗潜力和药理学见解:综述

本文引用的文献

1
Refractory Vasospastic Angina: When Typical Medications Don't Work.难治性血管痉挛性心绞痛:当典型药物无效时。
Cureus. 2019 Feb 25;11(2):e4134. doi: 10.7759/cureus.4134.
2
High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction.冠心病患者的高冠状动脉剪切应力可预测心肌梗死。
J Am Coll Cardiol. 2018 Oct 16;72(16):1926-1935. doi: 10.1016/j.jacc.2018.07.075.
3
Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis.非阻塞性冠状动脉粥样硬化患者的局部低切应力与内皮功能障碍。
Front Pharmacol. 2025 Jan 2;15:1423717. doi: 10.3389/fphar.2024.1423717. eCollection 2024.
4
Coronary Artery Spasm: Risk Factors, Pathophysiological Mechanisms and Novel Diagnostic Approaches.冠状动脉痉挛:危险因素、病理生理机制及新型诊断方法
Rev Cardiovasc Med. 2022 May 16;23(5):175. doi: 10.31083/j.rcm2305175. eCollection 2022 May.
5
Diagnostic Puzzles and Cause-Targeted Treatment Strategies in Myocardial Infarction with Non-Obstructive Coronary Arteries: An Updated Review.非阻塞性冠状动脉心肌梗死的诊断难题及病因针对性治疗策略:最新综述
J Clin Med. 2023 Sep 26;12(19):6198. doi: 10.3390/jcm12196198.
6
The Role of Antiplatelet Therapy in Patients With MINOCA.抗血小板治疗在心肌梗死合并非阻塞性冠状动脉疾病患者中的作用
Front Cardiovasc Med. 2022 Feb 14;8:821297. doi: 10.3389/fcvm.2021.821297. eCollection 2021.
7
Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries?无冠状动脉阻塞患者的冠状动脉迂曲与血管舒缩功能障碍之间的关系?
Front Cardiovasc Med. 2022 Jan 13;8:804731. doi: 10.3389/fcvm.2021.804731. eCollection 2021.
8
Pathophysiology and Diagnosis of Coronary Functional Abnormalities.冠状动脉功能异常的病理生理学与诊断
Eur Cardiol. 2021 Sep 3;16:e30. doi: 10.15420/ecr.2021.23. eCollection 2021 Feb.
J Am Coll Cardiol. 2018 May 15;71(19):2092-2102. doi: 10.1016/j.jacc.2018.02.073.
4
The Who, What, Why, When, How and Where of Vasospastic Angina.变异性心绞痛的何人、何事、为何、何时、如何及何地
Circ J. 2016;80(2):289-98. doi: 10.1253/circj.CJ-15-1202. Epub 2015 Dec 18.
5
2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside.2014 年威廉姆斯·哈维讲座:从基础到临床看冠状动脉血管运动异常的重要性。
Eur Heart J. 2014 Dec 1;35(45):3180-93. doi: 10.1093/eurheartj/ehu427. Epub 2014 Oct 29.
6
Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013).变异性心绞痛(冠状动脉痉挛性心绞痛)患者的诊断和治疗指南(日本循环学会2013年版)
Circ J. 2014;78(11):2779-801. doi: 10.1253/circj.cj-66-0098. Epub 2014 Sep 30.
7
Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association.血管痉挛性心绞痛患者的预后分层:日本冠状动脉痉挛协会制定的综合临床风险评分。
J Am Coll Cardiol. 2013 Sep 24;62(13):1144-53. doi: 10.1016/j.jacc.2013.07.018. Epub 2013 Jul 31.
8
Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.白细胞 Rac 相关卷曲螺旋蛋白激酶活性升高预测冠状动脉痉挛性心绞痛的存在和严重程度。
Atherosclerosis. 2012 Apr;221(2):521-6. doi: 10.1016/j.atherosclerosis.2012.01.001. Epub 2012 Jan 12.
9
Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina.光学相干断层成像术评估血管痉挛性心绞痛患者冠状动脉结构的构象变化。
J Am Coll Cardiol. 2011 Oct 4;58(15):1608-13. doi: 10.1016/j.jacc.2011.06.046.
10
Functional medial thickening and folding of the internal elastic lamina in coronary spasm.冠状动脉痉挛时的中层功能性增厚和内弹力层褶皱。
Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H423-30. doi: 10.1152/ajpheart.00959.2010. Epub 2010 Dec 17.